Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-26-017844
Filing Date
2026-04-29
Accepted
2026-04-29 16:46:13
Documents
14
Period of Report
2026-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20071620x1_def14a.htm   iXBRL DEF 14A 567185
3 GRAPHIC sig_mahermasoud.jpg GRAPHIC 21257
4 GRAPHIC ny20071620x1_pc01x1.jpg GRAPHIC 568881
5 GRAPHIC ny20071620x1_pc02x1.jpg GRAPHIC 407958
  Complete submission text file 0001140361-26-017844.txt   3388509

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA mxct-20260617.xsd EX-101.SCH 2152
17 EXTRACTED XBRL INSTANCE DOCUMENT ny20071620x1_def14a_htm.xml XML 4229
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40674 | Film No.: 26917280
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)